Microvascular Complications of Impaired Glucose Tolerance

作者: J. R. Singleton , A. G. Smith , J. W. Russell , E. L. Feldman

DOI: 10.2337/DIABETES.52.12.2867

关键词: CardiologyInternal medicinePostprandialImpaired glucose toleranceDiabetes mellitusInsulin resistanceStrokeEndocrinologyMedicineMyocardial infarctionPolyneuropathyImpaired fasting glucose

摘要: Impaired glucose tolerance (IGT) serves as a marker for the state of insulin resistance and predicts both large- small-vessel vascular complications, independent patient’s progression to diabetes. Patients with IGT are at significantly increased risk death morbidity due myocardial infarction, stroke, large-vessel occlusive disease. is more predictive cardiovascular than impaired fasting glucose, probably because it better surrogate resistance. also independently associated traditional microvascular complications diabetes, including retinopathy, renal disease, polyneuropathy, which topics this review. Inhibition nitric oxide-mediated vasodilation, endothelial injury release free fatty acids adipocytokines from adipocytes, direct metabolic end-organ cells contribute complications. Early detection allows intensive diet exercise modification, has proven effective drug therapy in normalizing postprandial inhibiting To what degree intervention will limit recognized not known.

参考文章(48)
Michael J. Aminoff, Neurology and general medicine : Churchill livingstone. ,(2012)
Victor E. Esenabhalu, Gabriela Schaeffer, Wolfgang F. Graier, Free Fatty Acid Overload Attenuates Ca2+ Signaling and NO Production in Endothelial Cells Antioxidants & Redox Signaling. ,vol. 5, pp. 147- 153 ,(2003) , 10.1089/152308603764816505
M. I. Harris, R. Klein, T. A. Welborn, M. W. Knuiman, Onset of NIDDM occurs at Least 4–7 yr Before Clinical Diagnosis Diabetes Care. ,vol. 15, pp. 815- 819 ,(1992) , 10.2337/DIACARE.15.7.815
R. Singh, A. Barden, T. Mori, L. Beilin, Advanced glycation end-products: a review. Diabetologia. ,vol. 44, pp. 129- 146 ,(2001) , 10.1007/S001250051591
C.J. Sumner, S. Sheth, J.W. Griffin, D.R. Cornblath, M. Polydefkis, The spectrum of neuropathy in diabetes and impaired glucose tolerance Neurology. ,vol. 60, pp. 108- 111 ,(2003) , 10.1212/WNL.60.1.108
L. Mykkanen, S. M. Haffner, J. Kuusisto, K. Pyorala, M. Laakso, Microalbuminuria Precedes the Development of NIDDM Diabetes. ,vol. 43, pp. 552- 557 ,(1994) , 10.2337/DIAB.43.4.552
Markus C Stühlinger, Fahim Abbasi, James W Chu, Cindy Lamendola, Tracey L McLaughlin, John P Cooke, Gerald M Reaven, Philip S Tsao, Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA. ,vol. 287, pp. 1420- 1426 ,(2002) , 10.1001/JAMA.287.11.1420
M. M. Gabir, R. L. Hanson, D. Dabelea, G. Imperatore, J. Roumain, P. H. Bennett, W. D. Knowler, Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes. Diabetes Care. ,vol. 23, pp. 1113- 1118 ,(2000) , 10.2337/DIACARE.23.8.1113
B. Isomaa, P. Almgren, T. Tuomi, B. Forsen, K. Lahti, M. Nissen, M.-R. Taskinen, L. Groop, Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome Diabetes Care. ,vol. 24, pp. 683- 689 ,(2001) , 10.2337/DIACARE.24.4.683